- Categories:About Us
- Time of issue:2020-03-04 00:00:00
Cosychem Technology(Tianjin) Co., Ltd. was founded in October 2010, headquartered in Tianjin Binhai New Area.It has developed into a national high-tech enterprise integrating R&D, production and technical services of genetic testing core raw materials and gene drug core raw materials.Cosychem wins the titles of “National Specialized and Innovative Small Giants Enterprise” ,“Tianjin Gazelle Enterprise” and “Tianjin Leading Enterprise in Strategic Emerging Industries”,etc.
Cosychem’s R&D center, pilot platform and production bases located in Tianjin, Hebei and Shandong. Relying on the excellent team and exquisite technology, Cosychem has expanded from R&D to mass production, realizing interdisciplinary and multi-field integration and breakthrough, and has formed two core technologies of cross-disciplinary interoperability and manufacturing innovation, and has established the innovation platform of small molecule chemical intermediates and API, the innovative process technology platform of chemical modification of nucleic acid, the technology platform of process development and purification for special compounds, the screening technology platform of highly selective LNP compounds, and the technology platform of nucleic acid drug disvovery, screening and validation, IVD testing Platform. Cosychem has laid out a number of product pipelines, became a enterprise focusing on scientific and technological innovation. Cosychem has accumulated profound technical reserves, and now has obtained more than 50 independent intellectual property rights. Cosychem’s technology in industry segments is at the leading level in China, solving the problems of technological bottleneck and international production monopoly.
Cosychem has strengthened the standardized management, comprehensively promoted the construction of various systems, successfully obtained the ISO9001, ISO14001, ISO45001 and intellectual property rights certification, and passed the integration of informatization and industrialization management system assessment. Cosychem has completed the A series funding amounted more than 100 million CNY by introducing strategic investment, focusing on the industrialization implementation of key technologies, manufacturing technology-leading products, committing to become the most reliable partner of the life sciences enterprises with innovative technology .
Cosychem is a science and technology company with new drug R&D as the most important task, technology innovation as the center.It will always adhere to the "sparing no effort, harmonious and coexistence, integrity and win-win" concept, commit to the R&D, manufacturing of high-tech product, and constantly optimize customer service, promote the development of the pharmaceutical industry with innovative scientific and technological achievements, benefit the society.